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ABSTRACT
Numerous procedures have been developed in recent
decades that claim to provide significant improvement in
myoma status without hysterectomy. However, what is
the cost in time and money of these procedures? This is a
review of the current literature regarding these recent
procedures to determine which, if any, is the best treat-
ment for myomas. We conducted a search of PubMed
using the terms “bipolar-, cryo-, radiofrequency, laparo-
scopic-, focused high-energy MRI-guided ultrasound, and
MRI-guided laser myolysis” to identify reports of the var-
ious procedures. Based on these published reports, we
describe the various types of myolysis performed in mul-
tiple patients in outpatient facilities including patient out-
comes, complications, cost, and efficiency of the proce-
dures.
Key Words: Myolysis, Laser myolysis, Cryo-myolysis, Ra-
diofrequency.
INTRODUCTION
The era of minimally invasive treatment of uterine fibroids
and menorrhagia was begun by Milton Goldrath in the early
1980s when he performed Nd:Yag laser endometrial ablation
on a young woman with persistent vaginal hemorrhage.
Goldrath,1 Neuwirth,2 and Vancaille3 have published their
data on endometrial ablation techniques. Falcone4 has sum-
marized the minimally invasive management of uterine fi-
broids. He included laparoscopic myomectomy, myolysis,
and uterine embolization. Laparoscopic myomectomy has
been advocated by Dubuisson5 and Miller6 as a safe, effec-
tive technique for treatment of fibroids. The problem re-
mains that the learning curve for laparoscopic surgeons is
steep, and blood loss and operating time can be extensive.
Based on a literature search of PubMed using the terms
“bipolar-, cryo-, radiofrequency, laparoscopic-, focused
high-energy MRI-guided ultrasound, and MRI-guided laser
myolysis,” we identified reports of the various procedures
currently being used to treat myomas. Herein, we review
the various methods of myolysis, which are alternatives to
hysterectomy, for the treatment of fibroid myomas.
MYOLYSIS
Myolysis was first performed by Mergui in France in 1987.
He used an Nd:YAG laser to make multiple punctures in
myomas with resultant tissue death and myoma shrink-
age. He presented this work in a video shown at the
European Association of Endoscopic Surgery meeting in
Lausanne, Switzerland in 1990.7
Leukens and Gallinat8 presented their work in a chapter of
Endoscopic Surgery in Gynecology published in Berlin in
1993. They used 1-cm to 3-cm bipolar needles to destroy
myoma tissue. Their technique was similar to that of
Mergui.
LAPAROSCOPIC MYOLYSIS
We performed the first myolysis in the United States in
1990.9 Early cases were accomplished using the laser tech-
nique, but after 1992 specially designed 5-cm sturdy bi-
polar needles were used to perform the procedures. Even-
tually, the needle technique replaced the laser completely.
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REVIEW ARTICLEA major premise of the procedure is that smaller fibroids
will yield better results than larger ones will. Therefore,
using depo GnRH agonists to preshrink the fibroid would
result in a smaller final size and improve the results.
Pretreating a 10-cm myoma with 12 weeks of depo agonist
resulted in a 40% reduction in size, and the postmyolysis
volume was again reduced by another 50%. In this man-
ner, a 10-cm myoma could ultimately be reduced to 4 cm
to 5 cm.
In 1992 in response to criticism that excessive adhesions
would develop as a result of damage to the visceral peri-
toneum overlying the myoma, the technique was reas-
sessed and changed. The modified approach was to per-
form circumferential punctures by using the 5-cm bipolar
needles. Each pass at 50 watts of coagulating current left
for 10 seconds to 15 seconds would result in a fraction of
the total circumferential tissue death. Obliterating the
feeding vessels with this approach would result in tissue
death without extensive peritoneal superficial tissue
trauma.
Additionally, we proposed the following criteria for
maximizing the success of the procedure.9
1. Limit the procedure to postreproductive
premenopausal women.
2. Limit the myoma size to 10 cm, which would have a
final result of 3 cm to 4 cm.
3. Administer GnRH agonist for 10 weeks to 12 weeks
to obtain maximal tissue shrinkage.
4. Discontinue the process of the GnRH agonist because
it does not result in a 30% to 40% reduction in myoma
size.
5. Treat menorrhagia concomitantly with a
hysteroscopic resection of submucosal myomas,
endometrial ablation, or both.
From 1986 to 1990 prior to the introduction of the myoly-
sis technique, we reported on 52 endometrial ablations10;
20/52 or 38% of the patients undergoing ablation alone
had significant recurrent bleeding and required a second
procedure. Of 88 myolysis procedures accompanied by
endometrial ablation and an additional 28 utilizing myoly-
sis and extensive resection of submucosal myomas, only
11/88 or 12.5% required a second procedure; 18% of the
resection patients and only 5.75% of endometrial ablation-
myolysis patients subsequently underwent hysterectomy.
Volumetric analysis of fibroid volume was conducted in
13 patients. Preoperative fibroid volumes ranged from 30
cm
3 to 363 cm
3 with a median of 111 cm
3. Following
pretreatment and surgery, the volume ranged from 1 cm
3
to 73 cm
3. Half of the patients experienced a reduction in
fibroid volume of at least 83%. The entire group experi-
enced an average reduction of 72.6%.
CRYOMYOLYSIS
In 2005, Exacoustos et al11 reported on 10 premenopausal
patients with a sonographic diagnosis of a single subse-
rosal or intramural uterine myoma, who underwent lapa-
roscopic cryomyolysis. The masses varied from 4 cm to 8
cm, and all patients were postreproductive. Exacoustos et
al11 excluded patients with suspected adenomyosis and
other significant gynecological conditions. Power Doppler
imaging was carried out in addition to standard 2D and 3D
sonography. Patients were evaluated at 1, 3, and 6
months. A total 52.6% reduction in myoma size was noted,
as was a significant reduction in central blood flow.
Cryomyolysis uses gas-cooled cryoprobes in which pres-
surized gas is expanded through a small orifice to produce
cooling. The temperature will drop to -90°C in 8 minutes
to 10 minutes, creating an expanding ice ball around the
probe with a transverse diameter of 3 cm to 4 cm and a
length of 5 cm to 7 cm. The ice ball can be monitored by
ultrasound. Although the entire ice ball does not reach
maximum cooling, Exacoustos et al11 note that tissue
death occurred at -20°C. Vascular reduction was immedi-
ately noted.
Although this procedure is quite effective in moderate-
sized myomas, the cost of the equipment, more than
$30,000 US, and the cost per case of $750 is significant.
Ciavattini et al12 in 2006 reported on 9 cases of pregnancy
after laparoscopic cryomyolysis. During the first 20 weeks
of gestation, the mean increase in cryo-treated myoma
volume was 71% (range, 21.8 to 97.7). Two myomas were
stationary, and 2 new ones appeared. Two patients had
early miscarriages, and the course of 7 other pregnancies
was normal. Four vaginal deliveries and 3 cesarean deliv-
eries took place.
It appears that the significant regrowth in fibroid volume
could be related to incomplete tissue death at the time of
initial treatment.
RADIOFREQUENCY ABLATION
Bruce Lee, MD13 performed the radiofrequency interstitial
tissue ablation (RITA) procedure, percutaneous insertion
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roscopic intraabdominal ultrasound guidance. After the
needle is inserted, smaller prongs are deployed into the
stroma of a given uterine myoma. Coagulative necrosis
results, and the fibroid is absorbed. The goal of this pro-
cedure is to coagulate only the internal structure of the
fibroid and not to impact normal endometrium. One pa-
tient has attempted pregnancy, and the infant was suc-
cessful and uneventfully delivered. Lee13 undertook a pro-
spective study of 125 patients; 70% of the patients had at
least one fibroid 4 cm, and 38% had a fibroid 6 cm.
The volume reduction was 40% at 36 months. In addition,
98% of the dysmenorrheal complaints disappeared by 6
months after treatment.
Bergamini et al14 in 2004 reported on 18 patients treated
with the radiofrequency technique (RITA Medical System,
Mountain View, CA), which involves a percutaneous nee-
dle system under laparoscopic guidance that is used to
puncture a given myoma and subsequently deploy mul-
tiple prongs in a Christmas tree configuration. The system
utilizes radiofrequency energy, which is an alternating
current with a frequency between 10 kHz and 900 kHz.
The heat generated by the electrical current is dissipated
at the electrode-tissue interface. Temperature above 50°C
melts cell membranes, proteins denature, and cell death
occurs. In only 3 of his patients were myomas greater that
6 cm. Median baseline volume was only 67 cm
3. However,
9 patients followed up for 12 months had an 85% reduc-
tion in volume.
UTERINE ARTERY EMBOLIZATION
In the 1990s in France, Ravina first introduced uterine
artery embolization as an elective procedure to treat fi-
broids. Ravina et al15 found that myoma size can be
reduced from 20% to 70% with improvement in uterine
bleeding and pain in up to 90% of patients. Proper selec-
tion of patients and reports of severe complications have
somewhat limited the popularity of the procedure. Pre-
mature menopause, expulsion of submucosal myomas,
infections, and misplacement of particulate matter have
been reported. The most glaring problem is that invasive
radiologists early on were embolizing very large fibroids
with bad results. If a 10-cm
3 myoma was reduced 40%, the
resulting volume was 8 cm
3. If a 20-cm
3 myoma was
embolized and reduced 40%, the resulting volume was 16
cm
3. In both instances, the reduction in size may not be
enough to relieve the patient’s symptoms. Katsumori et
al16 used gadolinium-enhanced MRI to determine the de-
gree of infarction after embolization. The volume of dom-
inant fibroids that were 100% infarcted was reduced
6018%, whereas volume of partly infracted myomas
declined by 35%.
The following is a statement by Malcolm Munro, MD17 in
the American Association of Gynecologic Laparoscopists
online chat room in response to comments concerning
urinary artery embolization (UAE):
The decision regarding appropriate patients for UAE
should not be in the hands of the interventional radiolo-
gist . . . it should be a collaborative decision made by the
patient and the gynecologist after considering all of the
options available for the treatment of her symptoms that
are presumed to be caused by uterine leiomyomas. In
general, these symptoms should not be related to myomas
that can be treated by hysteroscopically directed resec-
tion. Interventional radiologists are, in this situation, tech-
nicians . . . they do not have the training or ability to make
such decisions absent the counseling provided by a gy-
necologist unimpeded by biases that relate to lost revenue
or presumptions of the universal superiority of surgical
interventions. Please do not teach your residents that
“definitive surgery” is only hysterectomy as implied in
your note . . . for most women appropriately selected,
UAE is “definitive” . . . as is hysteroscopic myomectomy
for submucous myomas, the levonorgestrel releasing IUD
for heavy menstrual bleeding, or laparoscopic or lapa-
rotomic myomectomy for myoma-related pressure symp-
toms....T h eterm “definitive” has been manipulated to
suggest that hysterectomy is the only therapy that is “guar-
anteed” to produce results; while true, such a contention
often levers patients into selecting an approach that is
often more than they need.
MRI-GUIDED PERCUTANEOUS ABLATION
Law and Regan18 reported on uterine myomas treated
with cryotherapy and lasers. Although this procedure can
be performed with local anesthesia, a high incidence of
major perioperative complications has been reported.18
MRI-GUIDED FOCUSED ULTRASOUND
Stewart et al19 have shown the technique of delivering
intensely focused ultrasound to destroy uterine fibroids
with MRI guidance to be effective in reducing fibroid
volume.
Fennessy et al20 report significant improvement in symp-
toms with magnetic resonance (MR) imaging-guided fo-
cused ultrasound surgery to treat uterine leiomyomas in a
prospective study using 2 treatment protocols, an original
(96 patients) and a modified protocol (64 patients). The
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6, and 12 months after treatment was used to analyze
outcomes. Adverse events (AEs) were also noted. Patients
in the modified group had a significantly greater SSS
decrease at 3 months (P0.037) than did those in the
original group, and 73% of the original group and 91% of
the modified group had a 10-point decrease in SSS at 12
months. The modified group had fewer AEs than did the
original group (13% vs 25% reporting no event). Alterna-
tive treatments were chosen by fewer in the modified
group (28%) than in the original group (37%). This study
indicates that MR imaging-guided focused ultrasound sur-
gery results in improved symptoms for up to 12 months
after treatment. Greater clinical effectiveness and fewer
AEs resulted from treatment with the modified protocol.
The time required to perform the procedure varies from 2
hours to 4 hours. The cost of the equipment of over $1
million makes the cost of the procedure prohibitive. Com-
plications reported include skin burns and nerve injury.21
MECHANICAL UTERINE ARTERY OCCLUSION
During uterine artery embolism, the occlusion of uterine
vessels yields only transient ischemia. Fred Burbank,
MD22 has postulated that after occlusion, blood within the
myometrium clots and the myometrium becomes hy-
poxic. Hours later, the clots lyse, and the myometrium
becomes reperfused through collateral arteries and be-
comes normal after one month.
Olave Istre, MD23 of Oslo Norway used a Doppler-guided
paracervical clamp to occlude the uterine arteries. Each of
the 2 clamp blades is connected to a Doppler device, and
blood flow can be heard and measured. When placed
correctly, the flow disappears and the result is similar to
uterine embolization. The patient is kept with an epidural
block for 4 hours to 6 hours and is then released. Postop-
erative MRI studies have shown fibroid death similar to
that occurring with embolization. Although patients still
have postembolization pain, there are no surgical compli-
cations. A major issue is the potential crushing effect on
the ureter. Lichtinger24 observed the effect on the ureter
with no untoward results.
TRANSCERVICAL MYOLYSIS-ASSISSTED BY
TRANSVAGINAL ULTRASONIC GUIDANCE
Kanaoka et al25 report a preliminary study of 10 patients
with severe abnormal bleeding scheduled for microwave
endometrial ablation but subsequently undergoing tran-
scervical microwave myolysis using a guiding needle set
in a puncture adaptor attached to a transcervical ultrasonic
probe and a microwave applicator 1.6-mm in diameter.
Myoma shrinkage was measured at 3 months and 6
months. In 9 patients with either mostly submucosal or
intramural myomas of 4.0 cm to 7.5 cm, the tissue was
necrotized. Myomas were reduced in size by 36% to 69%
at 6 months. Rene Marty and Jacques Hamu in Paris also
advocate this procedure. They used the hysteroscopic
approach with needle electrosurgery.
This approach opens a new venue for treating intrauterine
myomas that we previously treated with hysteroscopic
resection. The problem with the latter approach is that a
significant portion of the myomas was often invading
deep into the myometrium. Resection of these myomas
often resulted in continuing prolapse of the myoma into
the endometrium. A word of caution about performing
this procedure–the authors have incorporated into their
technique the performance of laparoscopy to ensure that
bowel is not attached to the uterus and the instillation of
3 liters of lactated Ringer’s solution intraabdominally to
obviate intestinal hyperthermia. Laparoscopy can be
avoided in the virginal abdomen without a history of
endometriosis or infection, or if the tumor is well within
the myometrium and more than 5 mm from the serosa.
CONCLUSION
The procedures described above usher in a new genera-
tion in the field of women’s health. No longer is the
patronizing comment “you have had your children and
would be better off without your uterus” an ACCEPTABLE
APPROACH. Yes, there are significant indications for hys-
terectomy, and the decision should be a joint one between
the patient and her physician. Most of the procedures
described above are offshoots of the original “myoma
coagulation” procedure, but many are more expensive
than myoma coagulation and have not yet been shown to
be more effective. The important point here is that alter-
native treatments for fibroids are available, and hysterec-
tomy is only ONE option, not THE option.
Reducing fibroid size and limiting detrimental effects of
menorrhagia is an outgrowth of the WOMENS movement
and the realization that hysterectomy avoidance satisfies
the emotional needs of many women to retain their or-
gans. It is physicians’ responsibility to familiarize them-
selves with alternative options and to guide and assist
their patients by offering the most patient-friendly, cost-
effective, and safe procedure. Physicians also have an
obligation to refer patients for procedures they do not feel
comfortable performing. We should be advocates for our
patients. In the long run, everyone will benefit.
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